Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05692492
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Guangdong Raynovent Biotech Co., Ltd 180
Not applicableStudy completedNCT04369807
What this trial is testing

Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection

Who this might be right for
COVID-19
Perspectum 693
Not applicableLooking for participantsNCT05255978
What this trial is testing

A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.

Who this might be right for
the Effect of NAFLD on CHB
Qin Ning 10,000
Not applicableUnknownNCT05108415
What this trial is testing

Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test

Who this might be right for
NAFLDNASH - Nonalcoholic Steatohepatitis
HBI Solutions Inc. 1,500
Large-scale testing (Phase 3)WithdrawnNCT01384578
What this trial is testing

Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India
Testing effectiveness (Phase 2)Study completedNCT01876108
What this trial is testing

The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverLiver DysfunctionInsulin Resistance
Tehran University of Medical Sciences 100
Not applicableActive Not RecruitingNCT06445335
What this trial is testing

Prevalence of NAFLD in T2DM Patients

Who this might be right for
NAFLDT2DType 2 Diabetes+1 more
Ziekenhuis Oost-Limburg 385
Not applicableStudy completedNCT04462081
What this trial is testing

Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients

Who this might be right for
Nonalcoholic Steatohepatitis
University of California, San Diego 100
Not applicableStudy completedNCT04415112
What this trial is testing

Mediterranean Diet Treatment for NAFLD

Who this might be right for
Mediterranean Diet
Antalya Training and Research Hospital 45
Not applicableActive Not RecruitingNCT04795219
What this trial is testing

Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV

Who this might be right for
NAFLDNAFLD-HIVHiv
University of California, San Francisco 1,250
Not applicableStudy completedNCT04988633
What this trial is testing

"CAP" Fetge Gras. Lifestyle Modification Program in Catalonia.

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver DiseasesLifestyle, Healthy
Hospital Clinic of Barcelona 90
Large-scale testing (Phase 3)Active Not RecruitingNCT04833140
What this trial is testing

Estrogen Administration for the Treatment of NASH in Postmenopausal Women

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Massachusetts General Hospital 50
Not applicableUnknownNCT04850547
What this trial is testing

Effect of Fatty Liver Disease on Bone Density

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseOsteoporosis
Sohag University 80
Not applicableUnknownNCT03132662
What this trial is testing

Omega-3 vs Very Low Calorie Diet for Liver Size Reduction

Who this might be right for
Obesity, MorbidObesityNAFLD+1 more
McMaster University 60
Large-scale testing (Phase 3)Ended earlyNCT02704403
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Genfit 2,157
Testing effectiveness (Phase 2)WithdrawnNCT04761848
What this trial is testing

Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease

Who this might be right for
Fatty Liver, Nonalcoholic
Sadat City University
Large-scale testing (Phase 3)Study completedNCT01245608
What this trial is testing

Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.

Who this might be right for
Cardiovascular Diseases
Tehran University of Medical Sciences 2,400
Testing effectiveness (Phase 2)Study completedNCT03375788
What this trial is testing

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesityObesity, Abdominal+2 more
Massachusetts General Hospital 51
Early research (Phase 1)Study completedNCT02612662
What this trial is testing

Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
AstraZeneca 40
Post-approval studies (Phase 4)Study completedNCT01854463
What this trial is testing

The Effect of Vitamin D Supplementation in Type 2 Diabetes

Who this might be right for
DIABETES MELLITUS
Chuncheon Sacred Heart Hospital 158
Next Page